Skip to main content
[Replay] Medincell Presentation at the 23rd Annual Needham Virtual Healthcare Conference
April 11, 2024
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria
April 8, 2024
Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell’s Supervisory Board
March 13, 2024
[Replay] Medincell Presentation at Evercore ISI 2024 Emerging Biotech Conference
February 28, 2024
MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK)
January 31, 2024
Teva announces recruitment completion of phase 3 clinical study of mdc-TJK
January 9, 2024
Jefferies initiates MedinCell’s coverage with a “Buy” recommendation
January 4, 2024
Half-Year results (April 2023 – September 2023)
December 19, 2023
MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program
November 13, 2023
MedinCell at the 2023 Jefferies Global Healthcare Conference -London, 14-16 November
November 6, 2023
